Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,795
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Bavarian Nordic A/S - ADR market cap is $2.66B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bavarian Nordic A/S - ADR 52 week high is $12.72 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bavarian Nordic A/S - ADR 52 week low is $8.67 as of November 18, 2026.
Bavarian Nordic A/S - ADR stock price today is $11.73.
Bavarian Nordic A/S - ADR stock price yesterday was $11.80.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Bavarian Nordic A/S - ADR's P/E ratio is 19.1.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Bavarian Nordic A/S - ADR P/B ratio is 1.2971.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Bavarian Nordic A/S - ADR 50-day moving average is $11.51.